Dr. Mohamed Abulela | Environmental Chemistry | Best Researcher Award

Posted on 04/04/202504/04/2025 by Chemistry Awards

Dr. Mohamed Abulela | Environmental Chemistry | Best Researcher Award

Dr. Mohamed Abulela | Environmental Chemistry | Assiut university , Egypt

Dr. Mohamed Ahmed Mohamed Abdelazim Abulela is a skilled synthetic organic chemist from Assiut, Egypt, with extensive experience in both academic and industrial research. He serves as a full-time researcher at the Assiut Sugar Industry Technology Research Institute and a part-time lecturer at the Faculty of Science, New Valley Branch, Assiut University. He earned his Ph.D. in Organic Chemistry from Assiut University in 2010, focusing on selenium-containing heterocycles. His postdoctoral fellowship at Saurashtra University, India, enhanced his expertise in X-ray crystallography and selenium chelate synthesis. Dr. Abulela’s work includes the development of environmental chemistry friendly colorimetric methods, sugar quantification techniques, and biomass modification for adsorption and biofuel applications. His research contributes to sustainable practices in both chemistry and environmental science. With strong English and computer skills, he actively participates in international conferences and collaborative research initiatives.

Professional Profile :

Orcid

Summary of Suitability for Award:

Dr. Mohamed Abdelazim Abulela is highly suitable for the “Best Researcher Award”. His innovative methodologies, applied research relevance, and contribution to sustainable technologies in the fields of synthetic organic and environmental chemistry showcase the qualities expected of an awardee. His balanced presence in academia and industry, along with international collaborations and scientific publications, position him as a well-rounded, impactful researcher who deserves formal recognition for his ongoing scientific contributions.

🎓Education:

Dr. Abulela’s academic journey began with a B.Sc. in Chemistry from Assiut University in 1999, graduating with a “Very Good” general grade. He earned his M.Sc. in Organic Chemistry from the same institution in 2005, with a thesis on the synthesis of new triazepines with potential biological activity. Continuing his pursuit of advanced organic synthesis, he completed a Ph.D. in 2010, focused on the synthesis and application of heterocyclic compounds related to selenolopyridine derivatives. His academic excellence and research curiosity led him to a postdoctoral fellowship at Saurashtra University in Rajkot, India (2015–2016), where he specialized in X-ray crystallography and the synthesis of selenium chelates. His robust educational background laid a strong foundation for his career in chemical research, particularly in the design of novel bioactive compounds and green analytical methods. His academic formation reflects a commitment to innovation in synthetic organic and environmental chemistry.

🏢Work Experience:

Dr. Abulela has a diverse research portfolio combining synthetic organic chemistry and industrial bioprocessing. At the Assiut Sugar Industry Technology Research Institute, he has worked extensively on the synthesis of bioactive compounds, particularly triazepines and selenium-based heterocycles and chelates. He has contributed to the development of eco-friendly analytical methods for quantifying reducing sugars and ethanol in fermentation broths using non-toxic materials. His work also includes the valorization of sugarcane bagasse as a bioadsorbent for wastewater treatment and oil removal. He has determined enzymatic activity (invertase, amylase, cellulase) relevant to biofuel production. He played a key role in a national project under Prof. Dr. Abdelaziz A. Said, focused on bagasse modification for adsorptive applications. Alongside his full-time research, he lectures part-time at Assiut University’s New Valley branch, mentoring future chemists. His combined industrial and academic roles make him a valuable asset in applied and sustainable chemical sciences.

🏅Awards:

While specific awards are not listed in the available profile, Dr. Mohamed Abulela’s achievements reflect his recognized contributions to both academia and applied research. He was selected for a prestigious Postdoctoral Fellowship at Saurashtra University, India (2015–2016), where he contributed to international collaborative projects in drug design and crystallography. His participation in key events like German Science Day (2016) and international pharmacognosy conferences signals his active role in the global scientific community. His publications in indexed, peer-reviewed journals and his involvement in national-level research projects further underscore the recognition of his scientific capabilities. As a lecturer and researcher, he continues to inspire students and contribute significantly to Egypt’s industrial and environmental chemistry sectors. His consistent output, including innovative analytical techniques and eco-friendly applications, speaks to his dedication, earning him respect and distinction within the regional chemical research community.

🔬Research Focus:

Dr. Abulela’s research centers on synthetic organic chemistry with an emphasis on heterocyclic compounds, especially 1,2,4-triazepines and selenium-based molecules, including chelates. His work bridges fundamental synthesis with practical applications in bioactivity, analytical chemistry, and environmental chemistry. He has developed novel colorimetric methods for sugar and ethanol detection using safe, sustainable reagents. His interest in green chemistry is further demonstrated by projects modifying sugarcane bagasse into an effective adsorbent for dyes and oil removal in wastewater treatment. Dr. Abulela also investigates enzyme activity related to biofuel research and explores the use of bio-sorbents for eco-remediation. His expertise extends to X-ray crystallography, allowing for detailed structural characterization of synthesized compounds. By combining synthetic techniques with real-world industrial challenges, his work supports sustainable technological advancements in the sugar industry and beyond. His research contributes meaningfully to cleaner chemical practices and the development of low-cost, efficient solutions in applied chemistry.

Publication Top Notes:

“A Simplified Procedure for Cellulase Filter Paper Assay”

“Self-Colorimetric Determination of Bio-Ethanol Using Permanganate in Fermentation Samples”

“2-Aminoethanaminium 2-(ethoxycarbonyl)-4,6-dinitrophenolate as a Greener Route in Reducing Sugar Quantification”

“Modified Sugarcane Bagasse with Tartaric Acid for Removal of Diazonium Blue from Aqueous Solutions”

“A Simplified Procedures for Cellulase Filter Paper Assay” (Preprint)

Dr. Diba Kadivar | Inorganic Chemistry | Best Researcher Award

Posted on 15/03/202515/03/2025 by Chemistry Awards

Dr. Diba Kadivar | Inorganic Chemistry| Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Ph. D. graduate in inorganic chemistry at chemistry and chemical engineering research center of iran , Iran

Dr. Diba Kadivar is a Ph.D. graduate in Inorganic Chemistry with extensive expertise in anticancer platinum complexes. She has been serving as a technical assistant at the Iranian Food and Drug Administration (IFDA) for over eight years, contributing to pharmaceutical research and regulatory affairs. Dr. Kadivar has conducted significant studies on the synthesis, characterization, and biological activity of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and aliphatic N-substituted glycine derivatives on platinum complexes’ pharmacological properties. She has published multiple papers in reputed journals and actively collaborates on cancer cell line studies. Passionate about innovative drug discovery, she has contributed to the development of metal-based nanocomplexes for potential therapeutic applications. Dr. Kadivar remains committed to advancing medicinal inorganic chemistry through her research and collaborations, aiming to enhance the effectiveness of anticancer therapies while minimizing side effects.

Professional Profile :

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Dr. Diba Kadivar is a distinguished researcher in inorganic chemistry, specializing in anticancer platinum complexes. With a Ph.D. in inorganic chemistry and eight years of experience as a technical assistant at the Iranian Food and Drug Administration (IFDA), she has made notable contributions to the development of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and the role of aliphatic N-substituted glycine derivatives in enhancing the biological activities of platinum complexes. She has published in reputable journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications, with a citation index of 18. Dr. Diba Kadivar’s innovative research on platinum-based anticancer drugs, scientific contributions, and expertise in inorganic medicinal chemistry make her highly suitable for the “Best Researcher Award.” Her work advances cancer treatment strategies, and her publications demonstrate scientific excellence and impact in medicinal chemistry.

🎓Education:

Dr. Diba Kadivar pursued her doctoral studies in Inorganic Chemistry, specializing in metal-based drug development and anticancer platinum complexes. Her academic journey has been marked by a strong foundation in medicinal chemistry, with a keen interest in exploring the role of isomerism in drug efficacy. During her Ph.D., she conducted extensive research on platinum complexes with glycine derivatives, focusing on their interaction with DNA and anticancer properties. Her work involved molecular docking, dynamic simulations, and in-vitro studies to evaluate the pharmacological potential of these compounds. Through her research, she contributed to the field of coordination chemistry and its applications in medicine. She has actively participated in international conferences, presenting her findings on novel platinum-based therapies. With a passion for drug discovery, Dr. Kadivar continues to apply her expertise in chemistry to enhance the effectiveness of anticancer agents.

🏢Work Experience:

Dr. Diba Kadivar has accumulated over eight years of professional experience as a technical assistant at the Iranian Food and Drug Administration (IFDA). In this role, she has been actively involved in regulatory affairs, pharmaceutical analysis, and drug quality control, ensuring the safety and efficacy of therapeutic compounds. Alongside her administrative responsibilities, she has played a vital role in cancer research, working in laboratory settings to study platinum-based anticancer agents. Her expertise extends to working with cancer and normal cell lines, contributing to drug screening and cytotoxicity assays. Additionally, she has been involved in synthesizing and characterizing novel platinum complexes, focusing on their pharmacological interactions. Dr. Kadivar also collaborates with academic institutions and research centers, aiming to bridge the gap between regulatory science and drug discovery. Her hands-on experience in both research and regulatory affairs makes her a key contributor to pharmaceutical advancements in Iran.

🏅Awards:

Dr. Diba Kadivar has been recognized for her contributions to inorganic and medicinal chemistry, particularly in the field of platinum-based anticancer research. She has received accolades for her pioneering work on the role of geometric isomerism in anticancer drug efficacy. Her research has been acknowledged at national and international scientific conferences, where she has been invited as a speaker and presenter. She has also played a key role in regulatory initiatives at the Iranian Food and Drug Administration, contributing to drug quality assurance and research-based policy-making. Additionally, her publications in esteemed journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications have received notable citations, highlighting her impact on the field. Dr. Kadivar’s dedication to advancing cancer therapy and pharmaceutical sciences continues to earn her recognition among her peers, further solidifying her reputation as an innovative researcher in medicinal inorganic chemistry.

🔬Research Focus:

Dr. Diba Kadivar’s research primarily revolves around the synthesis, characterization, and biological evaluation of platinum-based anticancer complexes. She investigates the impact of geometric isomerism on drug efficacy, focusing on how structural variations influence DNA interactions and cytotoxicity. Her studies explore novel ligand designs, particularly aliphatic N-substituted glycine derivatives, to enhance the pharmacological properties of platinum complexes. In addition to drug synthesis, she conducts in-vitro studies on cancer and normal cell lines to assess the cytotoxic potential of these compounds. She is also involved in molecular docking and dynamic simulations to predict drug interactions at the molecular level. Furthermore, she has worked on calcium, magnesium, copper, and zinc glycine edible nanocomplexes, aiming to develop biocompatible metal-based therapies. Through her interdisciplinary approach, Dr. Kadivar contributes to bridging chemistry and medicine, paving the way for new, targeted anticancer treatments with improved therapeutic outcomes.

Publication Top Notes:

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

Authors: K. Nikoofar, D. Kadivar, S. Shirzadnia

Citations: 13

Year: 2014

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Authors: D. Kadivar, M. E. Moghadam, B. Notash

Citations: 5

Year: 2024

Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

Authors: D. Kadivar, M. E. Moghadam, M. Rezaeisadat

Year: 2025

Dr. Minitha R | Inorganic Chemistry | Best Researcher Award

Posted on 28/02/202528/02/2025 by Chemistry Awards

Dr. Minitha R | Inorganic Chemistry | Best Researcher Award

Dr. Minitha R ,Inorganic Chemistry, GOVERNMENT POLYTECHNIC COLLEGE, EZHUKONE, KOLLAM, KERALA, India

Dr. Minitha R. is an Associate Professor with over 14 years of teaching and 15 years of research experience in chemistry. She holds an M.Sc., M.Phil., NET, UGC-JRF, and Ph.D. Her expertise spans organic, coordination, supramolecular, and inorganic chemistry. She has served in key academic roles, including NSS Programme Officer and Chief Superintendent of Examinations. A dedicated researcher, Dr. Minitha has guided students and undertaken projects like developing a chemosensor for metal ion detection. She has organized multiple national seminars and actively participates in international conferences and workshops.

Professional Profile :

Orcid

Scopus

Summary of Suitability for Award:

Dr. Minitha R., an accomplished Associate Professor with 15 years of research experience, has significantly contributed to the field of Inorganic Chemistry, particularly in Coordination Chemistry, Supramolecular Chemistry, and Organic Chemistry. With a strong publication record, she has authored several impactful research papers in highly reputed journals, covering diverse topics such as metal complexes, chemosensors, molecular structures, and spectroscopic studies. Dr. Minitha R. is an exceptional candidate for the “Best Researcher Award,” given her proven research excellence, scholarly contributions, and leadership in the scientific community. Her extensive work in metal-based coordination complexes, chemosensors, and supramolecular chemistry, along with her active role in mentoring and academic leadership, makes her a highly deserving nominee.

🎓Education:

Dr. Minitha R. holds a Ph.D. in Chemistry and has qualified for the NET and UGC-JRF. She completed her M.Sc. and M.Phil. in Chemistry, demonstrating academic excellence throughout. Her education provided her with a strong foundation in inorganic chemistry, particularly in complex synthesis, supramolecular interactions, and chemosensing applications. Her academic journey was driven by a passion for molecular recognition, ligand design, and structural chemistry. She has actively participated in seminars and workshops to enhance her knowledge and keep up with evolving research trends.

🏢Work Experience:

With 14 years of teaching and 15 years of research experience, Dr. Minitha R. has handled Organic, Inorganic, and Physical Chemistry courses. She has successfully guided research scholars, fostering innovations in supramolecular and coordination chemistry. Apart from teaching, she has played key roles as an NSS Programme Officer, Nature Club Coordinator, Chief Superintendent of Examinations, and Young Innovators Programme Facilitator. She has also organized national seminars and workshops on emerging trends in chemistry, enhancing academic collaboration and knowledge dissemination.

🏅Awards:

Dr. Minitha R. has been recognized for her outstanding contributions to academia and research. She served as the NSS Programme Officer (2021-2022), demonstrating her commitment to student welfare and community service. As the Nature Club Coordinator (2019-2020), she played a crucial role in promoting environmental awareness. Her leadership extended to being the Chief Superintendent of Examinations (2020-2021), ensuring smooth academic assessments. Additionally, she facilitated the Young Innovators Programme (2019), fostering creativity and scientific curiosity among students. Her research endeavors were supported by a KSCSTE-funded M.Sc. student project, where she developed a chemosensor for metal ion detection. These roles reflect her dedication to education, research, and institutional development.

🔬Research Focus:

Dr. Minitha R. specializes in Inorganic Chemistry, with a keen interest in Organic Chemistry, Coordination Chemistry, and Supramolecular Chemistry. Her research explores the synthesis and characterization of novel metal complexes, particularly those with biological and chemosensory applications. She has contributed significantly to the development of pyrazolylhydrazone-based metal complexes, dioxo molybdenum(VI) compounds, and benzothiazolium salts. Her work also extends to fluorescent hydrazones and ruthenium(II) complexes, emphasizing their structural and functional properties. Additionally, her studies on five-coordinate Zn(II) complexes highlight their potential in nonlinear optical applications. Through her research, she aims to bridge the gap between fundamental chemistry and real-world applications, particularly in materials science, catalysis, and medicinal chemistry.

Publication Top Notes:

Formation of dicyano ruthenium(II) complex mediated by triethylamine via deprotonation of hydrazonochroman-2,4-dione

Synthesis, spectroscopic and biological studies of metal complexes of an ONO donor pyrazolylhydrazone – Crystal structure of ligand and Co(II) complex

Studies of some dioxo molybdenum(VI) complexes of a polydentate ligand

One pot synthesis of 1–(3–methyl–4H–benzo[1,4]thiazin–2–yl)-ethanone and its antimicrobial properties

Synthesis, spectral, and magnetic studies of benzothiazolium tetrachlorocuprate salts: crystal structure and semiconducting behavior of bis[2-(4-methoxyphenyl)benzothiazolium] tetrachlorocuprate(II)

Fluorescent coumarin-based hydrazone: Synthesis, crystal structure, and spectroscopic studies

FT-IR, FT-Raman and computational study of 1H-2,2-dimethyl-3H-phenothiazin-4[10H]-one

Synthesis, crystal structure, spectral analysis, and NLO studies of five-coordinate Zn(II) complexes of hydrazochromandione

Chemosensing study of 1,4-Benzothiazine generated from acetylacetone

Prof. Massimo Padalino | Medicinal Chemistry | Excellence in Innovation Award

Posted on 21/02/2025 by Chemistry Awards

Prof. Massimo Padalino | Medicinal Chemistry | Excellence in Innovation Award

Prof. Massimo Padalino | Medicinal Chemistry | Professore associato at University of Bari, Italy

Dr. Massimo Antonio Padalino obtained his M.D. from the University of Padova, Italy, in 1995. He completed his residency in Cardiovascular Surgery at the University of Padova Medical School (1995-1999), where he served as Chief Resident (1999-2000). He pursued advanced surgical training through prestigious fellowships, including a Surgical Clinical Fellowship in Cardiovascular Surgery at the Mayo Clinic, USA (2001-2002), and specialized training in Pediatric Cardiovascular Surgery at Boston Children’s Hospital, Harvard Medical School (2002), and Mott Children’s Hospital, University of Michigan (2003-2004). He earned a Ph.D. in Cardiovascular Sciences from the University of Padova (2005-2008) and further specialized with a Master’s degree in Cardiovascular Pathology (2011) and Pediatric Cardiology (2014). Additionally, he completed a research fellowship at the Cardiac Registry, Harvard Medical School, and a visiting fellowship at Johns Hopkins Hospital (2015), solidifying his expertise in congenital and pediatric cardiac surgery.

Professional Profile :

Orcid

Scopus

Summary of Suitability for Award:

Dr. Massimo Antonio Padalino is an outstanding candidate for the “Excellence in Innovation Award” due to his pioneering contributions to pediatric and congenital cardiovascular surgery. His research has led to innovative surgical techniques for congenital heart disease, particularly in neonatal and single-ventricle repairs. His work on novel bioprosthetic materials, cardiac regeneration, and mechanical circulatory support (ECMO, VAD) has significantly improved patient outcomes. He has also played a key role in international registries (EUROFONTAN, EUROAAOCA) and multicenter studies, advancing global knowledge in congenital heart surgery. His collaboration with premier institutions like Harvard Medical School and Mayo Clinic further highlights his commitment to innovation. Dr. Padalino’s groundbreaking work in pediatric cardiac surgery, including innovative surgical strategies, regenerative medicine, and advanced circulatory support techniques, makes him highly suitable for the “Excellence in Innovation Award.” His contributions have transformed congenital heart disease treatment, making a lasting impact on the field.

🎓Education:

Dr. Massimo Antonio Padalino obtained his M.D. from the University of Padova in Italy. He completed his residency in Cardiovascular Surgery at the University of Padova Medical School (1995-1999), where he served as Chief Resident (1999-2000). He pursued advanced surgical training through prestigious fellowships, including a Surgical Clinical Fellowship in Cardiovascular Surgery at the Mayo Clinic, USA (2001-2002), and specialized training in Pediatric Cardiovascular Surgery at Boston Children’s Hospital, Harvard Medical School (2002), and Mott Children’s Hospital, University of Michigan (2003-2004). He earned a Ph.D. in Cardiovascular Sciences from the University of Padova (2005-2008) and further specialized with a Master’s degree in Cardiovascular Pathology (2011) and Pediatric Cardiology (2014). Additionally, he completed a research fellowship at the Cardiac Registry, Harvard Medical School, and a visiting fellowship at Johns Hopkins Hospital (2015), solidifying his expertise in congenital and pediatric cardiac surgery.

🏢Work Experience:

Dr. Massimo Antonio Padalino has over two decades of experience in pediatric and congenital cardiovascular surgery. Since December 2023, he has served as Pediatric and Congenital Cardiac Surgeon in Chief at UOC Cardiochirurgia, University of Bari, Italy. Previously, he was a senior Pediatric and Congenital Cardiovascular Surgeon at the University of Padova Medical School (2004-2023), where he independently performed approximately 150 complex congenital heart surgeries annually, spanning neonates to adults. His expertise includes neonatal heart surgery, single-ventricle palliation, heart transplantation, and mechanical circulatory support (ECMO and VAD). His clinical training includes tenures at leading institutions such as Mayo Clinic, Boston Children’s Hospital, and the University of Michigan. He has also been actively involved in postoperative intensive care, clinical research, and multicenter studies, significantly contributing to advancements in pediatric cardiac surgery. His leadership extends to mentoring and training the next generation of cardiac surgeons.

🏅Awards:

Dr. Massimo Antonio Padalino has received numerous accolades for his contributions to pediatric and congenital cardiovascular surgery. He is a Fellow of the European Society of Cardiology (FESC) and has been recognized for his expertise in congenital heart disease management. His work in innovative surgical strategies and regenerative medicine has earned him invitations to speak at leading international cardiology and cardiac surgery conferences. He has also received research grants for pioneering studies in cardiac regeneration, bioprosthetic materials, and surgical outcomes in congenital heart disease. His collaborations with renowned institutions, including Harvard Medical School and the Mayo Clinic, have strengthened his reputation as a leading figure in pediatric cardiac surgery. His research and clinical excellence are reflected in his numerous high-impact publications, which have significantly influenced advancements in congenital heart surgery and pediatric cardiology worldwide.

🔬Research Focus:

Dr. Massimo Antonio Padalino’s research focuses on congenital heart disease surgery, particularly early repair techniques and novel surgical strategies for single-ventricle physiology. He actively contributes to international registries, including the EUROFONTAN and EUROAAOCA, studying surgical outcomes in congenital heart defects. His work explores innovative approaches to preserving pulmonary valve function in Tetralogy of Fallot repair and alternative strategies for managing end-stage heart failure in children, including ECMO, VAD, and pulmonary artery banding. Additionally, he investigates heart transplantation in congenital heart disease, cardiac regeneration in infants with dilated cardiomyopathy, and bioprosthetic materials for cardiac tissue reconstruction. His research also addresses the neurological and pulmonary effects of cardiopulmonary bypass in pediatric patients, aiming to improve outcomes and long-term survival. Through clinical trials and multicenter studies, Dr. Padalino is dedicated to advancing pediatric cardiac surgery, refining surgical techniques, and enhancing postoperative care for children with complex congenital heart conditions.